ArrowMark Colorado Holdings’s bluebird bio BLUE Stock Holding History

ArrowMark Colorado Holdings’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,103	Closed	-$39.5M	–	328
2017 Q4	$39.5M	Sell	17,103 -10,830	-39%	-$22M	0.4%	84
2017 Q3	$49.7M	Sell	27,933 -5,299	-16%	-$7.4M	0.56%	60
2017 Q2	$45.2M	Buy	33,232 +1,634	+5%	+$1.97M	0.56%	65
2017 Q1	$37.2M	Sell	31,598 -3,401	-10%	-$3.47M	0.51%	69
2016 Q4	$28M	Buy	34,999 +4,359	+14%	+$3.46M	0.44%	77
2016 Q3	$26.9M	Sell	30,640 -12,605	-29%	-$9.13M	0.49%	71
2016 Q2	$24.2M	Buy	43,245 +4,625	+12%	+$2.62M	0.49%	72
2016 Q1	$21.3M	Buy	38,620 +19,449	+101%	+$11.9M	0.47%	76
2015 Q4	$15.9M	Buy	+19,171	New	+$19.2M	0.44%	77
2015 Q3	–	Sell	-127	Closed	-$278K	–	281
2015 Q2	$278K	Buy	+127	New	+$259K	0.01%	291
2014 Q3	–	Sell	-193	Closed	-$96K	–	300
2014 Q2	$96K	Buy	+193	New	+$61.9K	﹤0.01%	325

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ArrowMark Colorado Holdings's BLUE Position: Q1 2018 in Review

ArrowMark Colorado Holdings sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 17,103 shares — an estimated $39.5M sold.

ArrowMark Colorado Holdings first reported a position in BLUE in Q2 2014 and held it in 11 quarters. The position peaked at $49.7M in Q3 2017. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

ArrowMark Colorado Holdings reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
ArrowMark Colorado Holdings sold 17,103 bluebird bio shares in Q1 2018, an estimated $39.5M.
ArrowMark Colorado Holdings first reported a position in bluebird bio in Q2 2014 and held it in 11 quarters.
ArrowMark Colorado Holdings's bluebird bio position peaked at $49.7M in Q3 2017.
303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2018, filed 15 May 2018.